A new peptide-based nanotube treatment sneaks chemo into drug-resistant cancer cells, providing a unique workaround to one of oncology’s toughest hurdles.
CiQUS researchers have developed a novel molecular strategy that allows a chemotherapy drug to enter the nucleus of tumor cells and exert its therapeutic impact, even in drug-resistant cancers. Their findings were published in ACS Applied Materials and Interfaces.
The study focused on doxorubicin, a commonly used chemotherapy drug. Prolonged treatment with this drug frequently results in the formation of resistant cells, which causes substantial difficulties in clinical use that the new approach successfully addresses, while maintaining the drug’s antitumor efficacy.
The technique is based on a simple but powerful concept: cyclic peptides (small amino acid rings) can stack and self-assemble into hollow cylindrical structures (nanotubes) on the surface of cancer cell membranes.
The molecular-scale drug delivery, created by a team led by Juan R. Granja, binds doxorubicin to these peptides and transports it to the cell nucleus via a mechanism that bypasses common drug resistance pathways, such as efflux pumps. This enables the drug to circumvent the cellular resistance mechanisms that typically render it ineffective.
Cancer cell membranes contain more negatively charged lipids than healthy cells. The cyclic peptides used in this study have a high affinity for these anionic surfaces, facilitating their interaction with tumor cells. Consequently, the peptide-drug conjugates enter resistant cells and go to the nucleus, where doxorubicin intercalates with DNA to produce its cytotoxic impact.
Critically, the efficacy of this delivery method depends on the structure of the cyclic peptide, particularly the inclusion of hydrophobic alkyl chains of specific lengths. Experimental research indicated that the chemical structure of the cyclic peptide is critical for the creation of stable nanotubes, which improves their capacity to penetrate malignant cells.
Drug resistance remains one of the most significant challenges in cancer therapy. Many tumors evolve systems to actively evade drugs, significantly reducing the efficacy of existing treatments. In this situation, cyclic peptides serve as multifunctional delivery vehicles, both enhancing uptake and shielding the drug from premature expulsion from tumor cells, allowing doxorubicin to enter cells that would otherwise reject it.
This technique, which combines selectivity, effective transport, and controlled drug release, opens the door to novel combination chemotherapies in which peptide-based nanotechnology might be a potent ally against cancer. Laboratory studies showed that versions of the peptide with ten carbon alkyl tails were the most effective, both in penetrating drug-resistant ovarian cancer cells and delivering doxorubicin to the nucleus.
The scientists anticipate that this method could spur the development of novel treatment techniques for difficult-to-treat tumors.
Journal Reference:
Vilela-Picos, M. et.al. (2025). Self-Assembling Cyclic Peptide Nanotubes for the Delivery of Doxorubicin into Drug-Resistant Cancer Cells. ACS Applied Materials and Interfaces. doi.org/10.1021/acsami.5c05264.
News
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
